Based on this result, we conclude that JNK-involved signaling pathway is the key target of metformin against Aβ-induced cytotoxicity, although we still cannot decide which stage of AD 200 μM Aβ is corresponding to by now. This evidence concerns the gene MAPK8 and Alzheimer disease.